References
- R. C. Gallo, S. Z. Salahuddin, M. Popovic, G. M. Shearer, M. Kaplan, B. F. Haynes, T. J. Palker, R. Redfield, J. Oleske and B. Safai, Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS, Science 224 (1984) 500-503; DOI: 10.1126/science.6200936.10.1126/science.62009366200936
- F. S. Barre, J. C. Chermann, F. Rey, M. T. Nugeyre, S. Chamaret, J. Gruest, C. Dauguet, C. Axler-Blin, F. Vezinet-Brun, C. Rouzioux, W. Rozenbaum and L. Montagnier, Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS), Science 220 (1983) 868-871; DOI: 10.1126/science.6189183.10.1126/science.61891836189183
- E. De Clercq, Toward improved anti-HIV chemotherapy: Therapeutic strategies for intervention with HIV infections, J. Med. Chem. 38 (1995) 2491-2517; DOI: 10.1021/jm00014a001.10.1021/jm00014a0017543152
- E. De Clercq, New developments in anti-HIV chemotherapy, Biochem. Biophys. Acta 1587 (2002) 258-275; DOI: 10.1016/S0014-827X (01)01007-2.
- D. Sriram, R. B. Tanushree and P. Yogeeswari, Design, synthesis and biological evaluation of novel non-nucleoside HIV-1 reverse transcriptase inhibitors with broad-spectrum chemotherapeutic properties, Bioorg. Med. Chem. 12 (2004) 5865-5873; DOI: 10.1016/j.bmc.2004.08.028.10.1016/j.bmc.2004.08.02815498662
- J. J. Ren, C. Nicolas, L. E. Bird, T. Fujiwara, H. Sugimoto and D. Stuart, Binding of the second generation non-nucleoside inhibitor S-1153 to HIV-1 reverse transcriptase involves extensive main chain hydrogen bonding, J. Biol. Chem. 275 (2000) 14316-14320; DOI: 10.1074/jbc.275.19. 14316.
- R. Silvestri, M. Artico, S. Massa, T. Marceddu, F. De Montis and P. La Colla, 1-[2-(Diphenylmethoxy) ethyl]-2-methyl-5-nitroimidazole: a potent lead for the design of novel NNRTIs, Bioorg. Med. Chem. Lett. 10 (2000) 253-256; DOI: 10.1016/S0960-894X (99)00664-2.
- R. Silvestri, M. Artico, G. De Martino, R. Ragno, S. Massa, R. Lodda, C. Mugioni, A. Giulia Loi, P. La Colla and A. Pani, Synthesis, biological evaluation and binding mode of novel 1-[2-(diarylmethoxy) ethyl]-2-methyl-5-nitroimidazoles targeted at the HIV-1 reverse transcriptase, J. Med. Chem. 45 (2002) 1567-1576; DOI: 10.1021/jm010904a.10.1021/jm010904a11931611
- G. De Martino, G. Regina, A. D. Pasquali, A. Bergamini, C. Ciaprini, A. Sinistro, G. Maga, E. Crespan, M. Artico and R. Silvestri, Novel 1-[2-(diarylmethoxy) ethyl]-2-methyl-5-nitroimidazoles as HIV-1 non-nucleoside reverse transcriptase inhibitors. A structure-activity relationship investigation, J. Med. Chem. 48 (2005) 4378-4388; DOI: 10.1021/jm050273a.10.1021/jm050273a15974590
- I. M. Lagoja, C. Pannecouque, Z. Debyser, J. Balzarini, A. V. Aerschot, M. Witvtouw and P. Herdewijn, N-Aminoimidazole derivatives inhibiting retroviral replication via a yet unidentified mode of action, J. Med. Chem. 46 (2003) 1546-1553; DOI: 10.1021/jm0211117.10.1021/jm021111712672256
- S. Ganguly, M. Sankaran, N. Prasanthi, O. Alptürk, B. Herman and N. S. Cremer, Synthesis and anti-HIV-1 activity of a novel series of aminoimidazole analogs, Lett. Drug Des. Discov. 7 (2010) 318-323; DOI: 10.2174/157018010791163424.10.2174/157018010791163424288230820535242
- S. Ganguly, V. Gopalakrishnan and R. Chandra, Synthesis and antibacterial activity of some new 1-substituted 2-methyl-4-nitroimidazoles, Int. J. Chem. Sci. 7 (2009) 204-210.
- M. Hoffer and E. Grunberg, Synthesis and antiprotozoal activity of 1-(3-chloro-2-hydroxypropyl)-substituted nitroimidazoles, J. Med. Chem. 17 (1974) 1019-1020; DOI: 10.1021/jm00255a026.10.1021/jm00255a0264370421
- Z. Soyer, F. S. Kilic, K. Erol and V. Pabuccuoglu, Synthesis and anticonvulsant activity of some ω-(1H-imidazol-1-yl)-N-phenylacetamide and propionamide derivatives, Farmaco 59 (2003) 595-600; DOI: 10.1016/j.farmac.2003.07.011.10.1016/j.farmac.2003.07.01115262528
- S. T. Selvi, V. Nadaraj, S. Mohan, R. Sasi and M. Hema, Solvent free microwave synthesis and evaluation of antimicrobial activity of pyrimido [4,5-b] and pyrazolo [3,4-b] quinolines, Bioorg. Med. Chem. 14 (2006) 3896-3903; DOI: 10.1016/j.bmc.2006.01.048.10.1016/j.bmc.2006.01.04816464602
- D. V. Nissley, J. Radzio, Z. Ambrose, C. W. Sheen, N. Hamamouch, K. L. Moore, G. Tachedjian and N. S. Cremer, Characterization of novel non-nucleoside reverse transcriptase (RT) inhibitor resistance mutations at residues 132 and 135 in the 51 kDa subunit of HIV-1 RT, Biochem. J. 404 (2007) 151-157; DOI: 10.1042/BJ20061814.10.1042/BJ20061814186883417286555
- A. L. Hopkins, J. Ren, R. M. Esnouf, B. E. Wilcox, E. Y. Jones, C. Ross, T. Miyasaka, R. T. Walker, H. Tanaka, D. K. Stammers and D. I. Stuart, Complexes of HIV-1 reverse transcriptase with inhibitors of the HEPT series reveal conformational changes relevant to the design of potent non-nucleoside inhibitors, J. Med. Chem. 39 (1996) 1589-1600; DOI: 10.1021/jm960056x.10.1021/jm960056x8648598
- W. L. Jorgensen, D. S. Maxwell and J. Tirado-Rives, Development and testing of the OPLS all-atom force field on conformational energetics and properties of organic liquids, J. Am. Chem. Soc. 118 (1996) 11225-11236; DOI: 10.1021/ja9621760.10.1021/ja9621760